TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,688,990 | +93.4% | 188,925 | +232.3% | 0.06% | +97.0% |
| Q2 2023 | $873,339 | +229.6% | 56,858 | +428.6% | 0.03% | +230.0% |
| Q3 2022 | $265,000 | -82.0% | 10,757 | -82.3% | 0.01% | -84.4% |
| Q2 2022 | $1,471,000 | +40.6% | 60,700 | +49.5% | 0.06% | +42.2% |
| Q1 2022 | $1,046,000 | +230.0% | 40,600 | +296.9% | 0.04% | +125.0% |
| Q4 2021 | $317,000 | +64.2% | 10,228 | -22.5% | 0.02% | +5.3% |
| Q2 2021 | $193,000 | – | 13,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |